Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (211-220 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Investigation|June 30, 2020
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's diseaseSouvarish Sarkar, Hai M Nguyen, Emir Malovic, et al.
Plos One|March 10, 2020
Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosisJavier Lozano-Gerona, Aida Oliván-Viguera, Pablo Delgado-Wicke, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 15, 2026
New mitochondrial K<sub>V</sub>1.3 conjugates are potent and specific inducers of apoptosis in cancer modelsŠpela Gubič, Marzia Fois, Xiaoyi Shi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Angewandte Chemie (International Ed. in English)|May 20, 2026
Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium CationsIvan Džajić, Natalija Trunkelj, Jernej Repas, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesChristine Beeton, Heike Wulff, Nathan E Standifer, et al.
Nature|December 10, 2020
A non-hallucinogenic psychedelic analogue with therapeutic potentialLindsay P Cameron, Robert J Tombari, Ju Lu, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant DefensinSeow Theng Ong, Saumya Bajaj, Mark R Tanner, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channelsStephen Ph Alexander, Alistair Mathie, John A Peters, et al.
Pageof 23

Showing results (211-220 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Investigation|June 30, 2020
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's diseaseSouvarish Sarkar, Hai M Nguyen, Emir Malovic, et al.
Plos One|March 10, 2020
Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosisJavier Lozano-Gerona, Aida Oliván-Viguera, Pablo Delgado-Wicke, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 15, 2026
New mitochondrial K<sub>V</sub>1.3 conjugates are potent and specific inducers of apoptosis in cancer modelsŠpela Gubič, Marzia Fois, Xiaoyi Shi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 4, 2014
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseasesSandeep Chhabra, Shih Chieh Chang, Hai M Nguyen, et al.
Angewandte Chemie (International Ed. in English)|May 20, 2026
Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium CationsIvan Džajić, Natalija Trunkelj, Jernej Repas, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesChristine Beeton, Heike Wulff, Nathan E Standifer, et al.
Nature|December 10, 2020
A non-hallucinogenic psychedelic analogue with therapeutic potentialLindsay P Cameron, Robert J Tombari, Ju Lu, et al.
Pharmacological Reviews|December 6, 2003
International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channelsGeorge A Gutman, K George Chandy, John P Adelman, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Modulation of Lymphocyte Potassium Channel K<sub>V</sub>1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant DefensinSeow Theng Ong, Saumya Bajaj, Mark R Tanner, et al.
British Journal of Pharmacology|September 16, 2021
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channelsStephen Ph Alexander, Alistair Mathie, John A Peters, et al.
Pageof 23